Ann: New CEO Appointed to Accelerate Global Growth, page-22

Bio, I share your view about Sygenus potential.
It would be good if we could get a status report on where things are up to with:
- commercialising the acne treatment;
- the Adelaide Uni/Macquarie Uni follow up to the Israeli study findings on use of Sygenus for pain management;
- current and planned studies into use of Sygenus for other specific medical/dermatological conditions.

i can’t see that there would be a commercial need for the company to be a secret squirrel about any of those 3 things.

zeno9